Drug Trial Radar · NCT07373613
A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension
Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
330
Planned (sponsor's estimate)
Start
Mar 1, 2026
Primary completion
Feb 1, 2027
Study completion Feb 1, 2027
Sponsor
- Lead sponsor
- Boryung Pharmaceutical Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Jan 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this clinical trial is to evaluate the antihypertensive efficacy and safety of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 with essential hypertension.
Conditions
- Essential Hypertension
Interventions
BR1400-1Drug
One tablet administered alone
BR1400-2Drug
One tablet administered alone
BR1400-3Drug
One tablet administered alone
BR1400-4Drug
One tablet administered alone
BR1400-5Drug
One tablet administered alone
BR1400-ADrug
One tablet administered alone
BR1400-BDrug
One tablet administered alone
BR1400-CDrug
One tablet administered alone
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline to treatment of 8 weeks in MSSBPTime frame: 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hanyang University Hospital
Soeul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.